Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P294. Back pain in inflammatory bowel disease patients
Authors:

L. Brakenhoff1, R. van den Berg2, F. van Gaalen2, A. van der Meulen-de Jong1, T. Huizinga2, D. van der Heijde2, D. Hommes3, H. Fidder4, 1Leiden University Medical Center, Gastroenterology and Hepatology, Leiden, Netherlands, 2Leiden University Medical Center, Rheumatology, Leiden, Netherlands, 3University of California Los Angeles, Center for Inflammatory Bowel Diseases, Los Angeles, United States, 4University Medical Center Utrecht, Gastroenterology and Hepatology, Utrecht, Netherlands

P294. Distal colitis: Evolution and prognosis during 10 years
P294. Does medical or surgical option influence quality of life in UC patients with a previous severe flare?
P294

Is the tuberculin skin test alone accurate in modeate-to-severe BCG vaccinated patients with Inflammatory Bowel Disease treated with immunosuppressives to test for latent tuberculosis?

Authors:

Z. Kurti*1, K. Gecse1, A. Balint2, K. Farkas2, B. Lovasz1, A. Szabo1, M. Mandel1, A. Gyurcsanyi1, K. Kristof3, Z. Vegh1, A. Mohas1, T. Molnar2, L. Kiss1, P.A. Golovics1, P. Lakatos1

1Semmelweis University, 1st Department of Medicine, Budapest, Hungary, 2University of Szeged, 1st Department of Medicine, Szeged, Hungary, 3Semmelweis University, Institute of Medical Microbiology, Budapest, Hungary

P295.

What is our success on complex perianal fistula healing in the clinic? From antibiotic to combined anti-TNF based treatment, ending with or without ileostomy

Authors:

Y. Erzin1, A. Ercaliskan2, I. Hatemi1, D. Eyice2, B. Baca3, N. Demir1, A.F. Celik1, 1Istanbul University Cerrahpasa Medical Faculty, Gastroenterology, Istanbul, Turkey, 2Istanbul University Cerrahpasa Medical Faculty, Internal Medicine, Istanbul, Turkey, 3Istanbul University Cerrahpasa Medical Faculty, General Surgery, Istanbul, Turkey

P295. Atypical distribution of inflammatory lesions in ulcerative colitis: is it really rare?
Authors:

S.H. Park1, S.-K. Yang1, S.-K. Park1, J.W. Kim1, D.-H. Yang1, K.W. Jung1, K.-J. Kim1, B.D. Ye1, J.-S. Byeon1, S.-J. Myung1, J.-H. Kim1, 1University of Ulsan College of Medicine, Asan Medical Center, Gastroenterology, Seoul, South Korea

P295. Prospective assessment of the adalimumab discontinuation during pregnancy in inflammatory bowel disease patients
P295. Treatment of acute or relapsing massive intestinal bleeding in Crohn's disease with anti-TNFα therapy
P295

Preliminary assessment of efficacy and safety of switching between originator and biosimilar infliximab in paediatric Crohn disease patients.

Authors:

D. Jarzebicka*1, A. Banaszkiewicz2, A. Plocek3, J. Sieczkowska1, A. Gawronska2, E. Toporowska-Kowalska3, J. Kierkus1

1The Children’s Memorial Health Institute, Department of Gastroenterology, Hepatology, Feeding Disorders and Pediatrics, Warsaw, Poland, 2Medical University of Warsaw, Department of Pediatric Gastroenterology and Nutrition, Warsaw, Poland, 3Medical University of Łódź, Department of Paediatric Allergology, Gastroenterology and Nutrition, Łódź, Poland

P296.

What happens to patients with paediatric onset inflammatory bowel disease (IBD) after transition to adult care and what is their view of the process?

Authors:

A. Bennett1,2, D. Moore3, P. Bampton2, J. Andrews1, 1Royal Adelaide Hospital, Gastroenterology and Hepatology, Adelaide, Australia, 2Flinders Medical Centre, Gastroenterology and Hepatology, Adelaide, Australia, 3Women's and Children's Hospital, Gastroenterology and Hepatology, Adelaide, Australia

P296. Association between autoantibodies against the gastric proliferative zone and inflammatory bowel disease
Authors:

K. Tozawa1, K. Hori2, K. Kamikoduru2, Y. Yokoyama2, S. Nakamura2, H. Miwa3, K. Fukunaga2, T. Matsumoto2, 1Hyogo College of Medicine, Department of Internal Medicine, Nishinomiya, Hyogo, Japan, 2Hyogo College of Medicine, Department of Internal Medicine, Division of Lower Gastroenterology, Nishinomiya, Hyogo, Japan, 3Hyogo College of Medicine, Department of Internal Medicine, Division of upper Gastroenterology, Nishinomiya, Hyogo, Japan

P296. CATS1 study: Immunomonitoring and clinical results of Treg cell therapy for Crohn's disease
P296. Evolution of the bone mineral density in patients with inflammatory bowel disease: A five year follow-up study
P296

Isoniazid prophylaxis may not prevent tuberculosis reactivation during anti-TNF treatment

Authors:

F. Akyuz1, R. Iliaz1, S. Evirgen1, S.Y. Onder2, K. Koksalan3, C. Karaca1, K. Demir1, F. Besisik1, S. Kaymakoglu*1

1Istanbul University, Department of Gastroenterology, Istanbul, Turkey, 2Istanbul University, Department of Pathology, Istanbul, Turkey, 3Istanbul University, Institute for Medical Experimental Research, Istanbul, Turkey

P297.

What do healthcare professionals know about fatigue in patients with IBD and how do they manage it?

Authors:

W. Czuber-Dochan1, C. Norton1, S. Berliner2, F. Bredin3, M. Darvell4, A. Forbes5, M. Gay6, I. Nathan7, E. Ream1, H. Terry4, 1King's College London, Florence Nightingale School of Nursing & Midwifery, London, United Kingdom, 2Crohn's and Colitis UK Trustee, Fatigue Steering Group, St Albans, United Kingdom, 3The Queen Elizabeth Hospital NHS Trust & Addenbrookes Hospital, Gastroenterology, King's Lynn & Cambridge, United Kingdom, 4Crohn's & Colitis UK Charity, CCUK, St Albans, United Kingdom, 5University College London, Gastroenterology, London, United Kingdom, 6Crohn's and Colitis UK, Fatigue Steering Group, St Albans, United Kingdom, 7University College London, Centre for Gastroenterology and Nutrition, London, United Kingdom

P297. Arthritis, sacroileal MRI and HLA-B27 in relation to PCDAI and quality of life in pediatric patients with Crohn's disease
Authors:

G. Veres1, B. Derfalvi2, G. Bozsaki1, D. Szabo1, K. Muller1, A. Arato1, 1Ist Dept. of Pediatrics, Budapest, Hungary, 2IInd Dept. of Pediatrics, Budapest, Hungary

P297. Cutaneous Crohn's disease
P297. Efficacy and safety of natalizumab in Crohn's disease patients treated at six academic Boston hospitals
P297

Utility of post-induction trough level measurement in planning infliximab maintenance therapy for pediatric IBD

Authors:

C. Popalis*, P.C. Church, K. Frost, J. Johnstone, T. Walters, A.M. Griffiths

The University of Toronto, Hospital for Sick Children, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Toronto, Canada

P298.

Vitamin D status and inflammatory bowel disease – the role in disease activity and quality of life

Authors:

F. Dias de Castro1, J. Magalhães1, P. Boal Carvalho1, M.J. Moreira1, P. Mota2, J. Cotter1, 1Centro Hospitalar do Alto Ave, Gastroenterology, Guimaraes, Portugal, 2Centro Hospitalar do Alto Ave, Clinical Pathology, Guimarães, Portugal